GSK says Antibody Drug Succeeds in Testing for Chronic Nasal Condition
Called depemokimab, the company’s treatment reduced the size of nasal polyps in two Phase 3 trials of people with chronic rhinosinusitis.
Chronic rhinosinusitis w...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.